PC
IFRX icon

Polar Capital’s InflaRx IFRX Stock Holding History

Polar Capital’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-141,887
Closed -$5.16M – 277
2018
Q4 		$5.16M Buy
141,887
+50,000
+54% +$1.54M 0.06% 209
2018
Q3 		$3.15M Buy
+91,887
New +$2.96M 0.03% 234

Other funds holding IFRX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Polar Capital's IFRX Position: Q1 2019 in Review

Polar Capital sold out of InflaRx (IFRX) in Q1 2019, closing a stake of 141,887 shares — an estimated $5.16M sold.

Polar Capital first reported a position in IFRX in Q3 2018 and held it in 2 quarters. The position peaked at $5.16M in Q4 2018. 46 funds tracked by Wall St. Rank hold IFRX as of Q1 2019.

  • Polar Capital reported no remaining InflaRx position as of Q1 2019 after selling out during the quarter.
  • Polar Capital sold 141,887 InflaRx shares in Q1 2019, an estimated $5.16M.
  • Polar Capital first reported a position in InflaRx in Q3 2018 and held it in 2 quarters.
  • Polar Capital's InflaRx position peaked at $5.16M in Q4 2018.
  • 46 funds tracked by Wall St. Rank held InflaRx as of Q1 2019.

Based on Polar Capital's 13F filing for Q1 2019, filed 15 May 2019.